Therapeutic Advances in Infectious Disease (Dec 2022)

The burden of surgical site infections and related antibiotic resistance in two geographic regions of Sierra Leone: a prospective study

  • Sulaiman Lakoh,
  • Le Yi,
  • James B.W. Russell,
  • Juling Zhang,
  • Stephen Sevalie,
  • Yongkun Zhao,
  • Joseph Sam Kanu,
  • Peng Liu,
  • Sarah K. Conteh,
  • Christine Ellen Elleanor Williams,
  • Umu Barrie,
  • Mohamed Gbessay Sheku,
  • Mohamed Boie Jalloh,
  • Olukemi Adekanmbi,
  • Darlinda F. Jiba,
  • Matilda N. Kamara,
  • Gibrilla F. Deen,
  • Joseph Chukwudi Okeibunor,
  • George A. Yendewa,
  • Xuejun Guo,
  • Emmanuel Firima

DOI
https://doi.org/10.1177/20499361221135128
Journal volume & issue
Vol. 9

Abstract

Read online

Introduction: Despite the prolongation of hospitalization, increase in morbidity, mortality and cost of care associated with both surgical site infections (SSIs) and antibiotic resistance, there are limited data on SSIs and antibiotic resistance to guide prevention strategies in Sierra Leone. Methods: This study assessed the burden of SSIs and related antibiotic resistance in the 34 Military Hospital (MH) and Makeni Government Hospital (MGH) located in two geographic regions of Sierra Leone using a prospective study design to collect data from adults aged 18 years or older. Results: Of the 417 patients, 233 (55.9%) were enrolled in MGH. Most were women 294 (70.5%). The incidence rate of SSI was 5.5 per 1000 patient-days, and the cumulative incidence of SSI was 8.2%. Common bacteria isolated in MH were Escherichia coli (6,33.3%) and Pseudomonas aeruginosa (3,16.7%) and in MGH were P. aeruginosa (3,42.9%) and Proteus mirabilis (2,28.9%). Of the gram-negative bacteria, 40% were Extended-spectrum beta-lactamase-producing Enterobacteriaceae , 33% were Carbapenem-resistant P. aeruginosa and 10% were carbapenem-resistant Enterobacteriaceae . Conclusion: Although the incidence of SSIs in our study is lower than previously reported, the rate of antibiotic resistance reported in this study is high. Urgent action is needed to invest in the microbiology infrastructure to support SSI surveillance and prevention strategies.